Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Fredun Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 1482.67 P/BV 5.61 Book Value ( ₹ ) 479.34
52 Week High/Low ( ₹ ) 2699/794 FV/ML 10/1 P/E(X) 45.45
Book Closure 23/06/2026 EPS ( ₹ ) 59.17 Div Yield (%) 0.03
(₹ in Crs.)

ParticularsMar 26Mar 25
Months1212
Source Of Info (AR = Annual Report, PR = Press Release)ARAR
FaceValue10.0010.00
   
   
INCOME  
Revenue From Operations [Net]633.33451.71
Other Operating Revenues2.142.11
Total Operating Revenues635.47453.82
   
Other Income3.662.45
Total Revenue639.12456.27
   
EXPENSES  
Cost Of Materials Consumed485.84323.98
Operating And Direct Expenses15.6717.56
Changes In Inventories Of FG,WIP And Stock-In Trade-31.696.05
Employee Benefit Expenses32.9422.23
Finance Costs39.3022.38
Depreciation And Amortisation Expenses8.255.04
Other Expenses41.8331.54
Total Expenses592.13428.77
   
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax47.0027.49
   
Profit/Loss Before Tax47.0027.49
   
Tax Expenses-Continued Operations  
Current Tax9.547.12
Deferred Tax2.060.64
Tax For Earlier Years2.770.00
Total Tax Expenses14.387.75
Profit/Loss After Tax And Before ExtraOrdinary Items32.6219.74
   
Profit/Loss From Continuing Operations32.6219.74
   
Profit/Loss For The Period32.6219.74
Consolidated Profit/Loss After MI And Associates32.6219.74
   
OTHER INFORMATION  
   
EARNINGS PER SHARE  
Basic EPS (Rs.)66.8141.78
Diluted EPS (Rs.)61.2342.53
   
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend0.330.33
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]633.33
Other Operating Revenues2.14
Total Operating Revenues635.47
Other Income3.66
Total Revenue639.12
EXPENSES 
Cost Of Materials Consumed485.84
Operating And Direct Expenses15.67
Changes In Inventories Of FG,WIP And Stock-In Trade-31.69
Employee Benefit Expenses32.94
Finance Costs39.30
Depreciation And Amortisation Expenses8.25
Other Expenses41.83
Total Expenses592.13
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax47.00
Profit/Loss Before Tax47.00
Tax Expenses-Continued Operations 
Current Tax9.54
Deferred Tax2.06
Tax For Earlier Years2.77
Total Tax Expenses14.38
Profit/Loss After Tax And Before ExtraOrdinary Items32.62
Profit/Loss From Continuing Operations32.62
Profit/Loss For The Period32.62
Consolidated Profit/Loss After MI And Associates32.62
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)66.81
Diluted EPS (Rs.)61.23
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.33
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.